These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 17027507)
1. Structure of complement component C2A: implications for convertase formation and substrate binding. Milder FJ; Raaijmakers HC; Vandeputte MD; Schouten A; Huizinga EG; Romijn RA; Hemrika W; Roos A; Daha MR; Gros P Structure; 2006 Oct; 14(10):1587-97. PubMed ID: 17027507 [TBL] [Abstract][Full Text] [Related]
2. The crystal structure of C2a, the catalytic fragment of classical pathway C3 and C5 convertase of human complement. Krishnan V; Xu Y; Macon K; Volanakis JE; Narayana SV J Mol Biol; 2007 Mar; 367(1):224-33. PubMed ID: 17234210 [TBL] [Abstract][Full Text] [Related]
3. The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation. Krishnan V; Xu Y; Macon K; Volanakis JE; Narayana SV Acta Crystallogr D Biol Crystallogr; 2009 Mar; 65(Pt 3):266-74. PubMed ID: 19237749 [TBL] [Abstract][Full Text] [Related]
4. Factor B structure provides insights into activation of the central protease of the complement system. Milder FJ; Gomes L; Schouten A; Janssen BJ; Huizinga EG; Romijn RA; Hemrika W; Roos A; Daha MR; Gros P Nat Struct Mol Biol; 2007 Mar; 14(3):224-8. PubMed ID: 17310251 [TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the A domain from complement factor B reveals an integrin-like open conformation. Bhattacharya AA; Lupher ML; Staunton DE; Liddington RC Structure; 2004 Mar; 12(3):371-8. PubMed ID: 15016353 [TBL] [Abstract][Full Text] [Related]
6. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation. Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650 [TBL] [Abstract][Full Text] [Related]
7. Multiple domains of MASP-2, an initiating complement protease, are required for interaction with its substrate C4. Duncan RC; Bergström F; Coetzer TH; Blom AM; Wijeyewickrema LC; Pike RN Mol Immunol; 2012 Jan; 49(4):593-600. PubMed ID: 22071314 [TBL] [Abstract][Full Text] [Related]
8. The C2A domain of synaptotagmin exhibits a high binding affinity for copper: implications in the formation of the multiprotein FGF release complex. Rajalingam D; Kumar TK; Yu C Biochemistry; 2005 Nov; 44(44):14431-42. PubMed ID: 16262243 [TBL] [Abstract][Full Text] [Related]
9. Conformational changes in a plant ketol-acid reductoisomerase upon Mg(2+) and NADPH binding as revealed by two crystal structures. Leung EW; Guddat LW J Mol Biol; 2009 May; 389(1):167-82. PubMed ID: 19362563 [TBL] [Abstract][Full Text] [Related]
10. Expression of functional recombinant von Willebrand factor-A domain from human complement C2: a potential binding site for C4 and CRIT. Hui KM; Orriss GL; Schirmer T; Magnadóttir B; Schifferli JA; Inal JM Biochem J; 2005 Aug; 389(Pt 3):863-8. PubMed ID: 15823096 [TBL] [Abstract][Full Text] [Related]
11. Structure of the alkalohyperthermophilic Archaeoglobus fulgidus lipase contains a unique C-terminal domain essential for long-chain substrate binding. Chen CK; Lee GC; Ko TP; Guo RT; Huang LM; Liu HJ; Ho YF; Shaw JF; Wang AH J Mol Biol; 2009 Jul; 390(4):672-85. PubMed ID: 19447113 [TBL] [Abstract][Full Text] [Related]
12. Role of the N-terminal helix in the metal ion-induced activation of the diphtheria toxin repressor DtxR. D'Aquino JA; Lattimer JR; Denninger A; D'Aquino KE; Ringe D Biochemistry; 2007 Oct; 46(42):11761-70. PubMed ID: 17902703 [TBL] [Abstract][Full Text] [Related]
13. Structural and active site analysis of plasmepsins of Plasmodium falciparum: potential anti-malarial targets. Bhargavi R; Sastry GM; Murty US; Sastry GN Int J Biol Macromol; 2005 Oct; 37(1-2):73-84. PubMed ID: 16242183 [TBL] [Abstract][Full Text] [Related]
14. Model for substrate interactions in C5a peptidase from Streptococcus pyogenes: A 1.9 A crystal structure of the active form of ScpA. Kagawa TF; O'Connell MR; Mouat P; Paoli M; O'Toole PW; Cooney JC J Mol Biol; 2009 Feb; 386(3):754-72. PubMed ID: 19152799 [TBL] [Abstract][Full Text] [Related]
15. MASP-1, a promiscuous complement protease: structure of its catalytic region reveals the basis of its broad specificity. Dobó J; Harmat V; Beinrohr L; Sebestyén E; Závodszky P; Gál P J Immunol; 2009 Jul; 183(2):1207-14. PubMed ID: 19564340 [TBL] [Abstract][Full Text] [Related]
16. Structural basis of carbohydrate transfer activity by human UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase (pp-GalNAc-T10). Kubota T; Shiba T; Sugioka S; Furukawa S; Sawaki H; Kato R; Wakatsuki S; Narimatsu H J Mol Biol; 2006 Jun; 359(3):708-27. PubMed ID: 16650853 [TBL] [Abstract][Full Text] [Related]
17. Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity. Papakyriakou A; Spyroulias GA; Sturrock ED; Manessi-Zoupa E; Cordopatis P Biochemistry; 2007 Jul; 46(30):8753-65. PubMed ID: 17605472 [TBL] [Abstract][Full Text] [Related]
18. Dynamics of catalysis revealed from the crystal structures of mutants of diaminopimelate epimerase. Pillai B; Cherney M; Diaper CM; Sutherland A; Blanchard JS; Vederas JC; James MN Biochem Biophys Res Commun; 2007 Nov; 363(3):547-53. PubMed ID: 17889830 [TBL] [Abstract][Full Text] [Related]
19. Human intestinal maltase-glucoamylase: crystal structure of the N-terminal catalytic subunit and basis of inhibition and substrate specificity. Sim L; Quezada-Calvillo R; Sterchi EE; Nichols BL; Rose DR J Mol Biol; 2008 Jan; 375(3):782-92. PubMed ID: 18036614 [TBL] [Abstract][Full Text] [Related]
20. Crystal structures of the conserved tRNA-modifying enzyme GidA: implications for its interaction with MnmE and substrate. Meyer S; Scrima A; Versées W; Wittinghofer A J Mol Biol; 2008 Jul; 380(3):532-47. PubMed ID: 18565343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]